LOGIN  |  REGISTER
Amneal Pharmaceuticals

Recent Insider Transactions - Acadia Pharmaceuticals (NASDAQ: ACAD)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ACAD Acadia Pharmaceuticals
Brege Laura / director
06/04/2025
Sell
$21.78
14,446
$315K
15,095
NASDAQ ACAD Acadia Pharmaceuticals
SOLAND DANIEL B / director
05/29/2025
Buy
$22.29
13,793
$307K
13,793
NASDAQ ACAD Acadia Pharmaceuticals
Ndu Adora / director
05/29/2025
Buy
$22.29
13,793
$307K
13,793
NASDAQ ACAD Acadia Pharmaceuticals
HARRIGAN EDMUND / director
05/29/2025
Buy
$22.29
13,793
$307K
13,793
NASDAQ ACAD Acadia Pharmaceuticals
GAROFALO ELIZABETH A. / director
05/29/2025
Buy
$22.29
13,793
$307K
13,793
NASDAQ ACAD Acadia Pharmaceuticals
Daly James M / director
05/29/2025
Buy
$22.29
13,793
$307K
13,793
NASDAQ ACAD Acadia Pharmaceuticals
Brege Laura / director
05/29/2025
Buy
$22.29
13,793
$307K
13,793
NASDAQ ACAD Acadia Pharmaceuticals
BAKER BROS. ADVISORS LP / director, 10 percent owner:
05/29/2025
Buy
$22.29
27,586
$615K
27,586
NASDAQ ACAD Acadia Pharmaceuticals
Kihara James / officer: PRINCIPAL ACCOUNTING OFFICER
05/16/2025
Sell
$25.00
2,000
$50K
22,395
NASDAQ ACAD Acadia Pharmaceuticals
Kihara James / officer: PRINCIPAL ACCOUNTING OFFICER
05/16/2025
Sell
$20.00
2,000
$40K
20,395
NASDAQ ACAD Acadia Pharmaceuticals
Schneyer Mark C. / officer: EVP, CHIEF FINANCIAL OFFICER
05/16/2025
Sell
$25.00
2,000
$50K
62,130